Trial Profile
Follow-up study of LDH patients participated in the Phase II/III study (6603/1021) and Phase III study (6603/1031) of condoliase (SI-6603)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 13 Mar 2015
Price :
$35
*
At a glance
- Drugs Condoliase (Primary)
- Indications Intervertebral disc displacement
- Focus Therapeutic Use
- Sponsors Seikagaku Corporation
- 10 Mar 2015 Status changed from recruiting to completed, as reported by University Hospital Medical Information Network - Japan record.
- 29 Sep 2014 New trial record